Evidence map›Paper›PMID 30425239›Full record

ArticleCell death & disease2018

Nitric oxide triggers the assembly of "type II" stress granules linked to decreased cell viability.

Anaïs Aulas, Shawn M Lyons, Marta M Fay, Paul Anderson, Pavel Ivanov

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Comparative analysis of wavelength-specific UV stress granule formation.bioRxiv : the preprint server for biology · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Connecting the Dots: Stress Granule and Cardiovascular Diseases.Journal of cardiovascular translational research · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Anaïs AulasDivision of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Shawn M LyonsDivision of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA, 02115, USA.ORCID http://orcid.org/0000-0002-2289-6392
Marta M FayDivision of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Paul AndersonDivision of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA, 02115, USA. panderson@rics.bwh.harvard.edu.
Pavel IvanovDivision of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA, 02115, USA. pivanov@rics.bwh.harvard.edu.ORCID http://orcid.org/0000-0002-7986-7760
Brigham and Women's Hospital · USBroad Institute · US

Funding

IMMUNOLOGIC BASIS OF RESISTANCE AND HYPERSENSITIVITYT32AI007306 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Nora Amanda Barrett, Joshua A Boyce · 1985 to 2026
$12.2M
Biology of RNA G-quadruplexesR01GM126150 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI IVANOV, PAVEL · 2019 to 2023
$1.9M
Stress granules and cell signalingR01GM111700 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI ANDERSON, PAUL J. · 2014 to 2017
$1.3M
Angiogenin-Induced RNA Cleavage in CancerR01CA168872 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ANDERSON, PAUL J. · 2013 to 2015
$1.1M
G-quadruplex Structures as Targets and Tools in ALSR21NS094918 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI IVANOV, PAVEL · 2015 to 2016
$488k
Characterization of tiRNA-mediated Translational RepressionF32GM119283 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI LYONS, SHAWN M · 2016 to 2017
$115k
Regulation of Ribosome Biogenesis During StressK99GM124458 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI LYONS, SHAWN M · 2018 to 2018
$90k
NCI NIH HHS R01 CA168872NIAID NIH HHS T32 AI007306NIGMS NIH HHS F32 GM119283NIGMS NIH HHS K99 GM124458NIGMS NIH HHS R01 GM111700NIGMS NIH HHS R01 GM126150NINDS NIH HHS R21 NS094918
6 · The paper itself

Abstract

We show that 3-morpholinosydnonimine (SIN-1)-induced nitric oxide (NO) triggers the formation of SGs. Whereas the composition of NO-induced SGs is initially similar to sodium arsenite (SA)-induced type I (cytoprotective) SGs, the progressive loss of eIF3 over time converts them into pro-death (type II) SGs. NO-induced SG assembly requires the phosphorylation of eIF2α, but the transition to type II SGs is temporally linked to the mTOR-regulated displacement of eIF4F complexes from the m

Indexed as

Adenosine TriphosphateAnimalsApoptosisApoptosis Regulatory ProteinsArsenitesCell Line, TumorCell SurvivalCytoplasmic GranulesEukaryotic Initiation Factor-2Eukaryotic Initiation Factor-3Eukaryotic Initiation Factor-4FFibroblastsGene Expression RegulationHumansMiceMitochondriaAdenosine TriphosphateApoptosis Regulatory ProteinsArsenitesEukaryotic Initiation Factor-2Eukaryotic Initiation Factor-3Eukaryotic Initiation Factor-4FlinsidomineMolsidomineMTOR protein, humanNitric OxideNitric Oxide DonorsReactive Oxygen Speciessodium arseniteSodium CompoundsTOR Serine-Threonine Kinases

Identifiers

PMID30425239
PMCPMC6234215
OpenAlexW2900968785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.